TerraForm Power Operating Fourth Quarter and Full-Year 2022
Date: Monday, March 20, 2023Time: 2:00 p.m. (Eastern Time) NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- You are
Globe Newswire16-03-2023, 04:59
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26